Treatment Action Group (TAG) released the latest installment of its 2026 Pipeline Report series on TB Vaccines, written by TB ...
Researchers discovered a previously unknown pathway that helps HIV stay hidden in the body, even when patients are taking ...
Dr Fiona Creswell, a physician and clinical researcher at the MRC/UVRI & LSHTM Uganda Research Unit explores what the IMPALA trial tells about the potential of long-acting HIV treatment in Africa, and ...
Investigational asuptegravir cut HIV-1 RNA by up to 2.36 log10 copies/mL in 10 days, and adding fostemsavir boosted CD4 gains in immunologic nonresponders.
In previously untreated adults with HIV-1, initiating therapy with either DOR/ISL or BIC/FTC/TAF results in comparable enhancements in overall health status.
Older HIV patients with metabolic comorbidities who transition to a single-tablet BIC/LEN experience low rates of severe adverse events and treatment discontinuations.
Recombinant zoster vaccination may reduce incident heart failure risk in adults with HIV, providing a protective effect against risks heightened by herpes zoster.
Achieving the UNAIDS global HIV targets for 2030 could reduce annual new HIV infections by 77%, according to a modeling study ...
The research, published in the Journal of NeuroVirology, found that among people living with HIV (PLWH), slower walking speed ...
Infectious Disease Advisor | Long-term ART does not reduce anogenital cancer risk in people with HIV
Despite immune function restoration, individuals with HIV who receive prolonged ART continue to face a substantially higher ...
Treatment resumption was the most difficult phase for participants who stopped HIV treatment in a trial aiming to find ...
More than a decade after WHO recommended HIV self-testing, a new analysis argues the technology’s promise has been squandered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results